iXCells Biotechnologies USA, Inc.
Accelerating drug discovery through disease-relevant cells
iXCells Biotechnologies USA, Inc. is a leading developer and manufacturer of high-quality human cells for preclinical drug discovery solutions, specializing in disease-relevant cellular models. Headquartered in San Diego, California, we are at the forefront of cell technology development.
Our primary objective is to accelerate the discovery of new treatments by delivering advanced cellular models and preclinical CRO services. We accomplish this by providing high-quality products and services to a broad range of clients in the academic, biotechnology, and pharmaceutical sectors. Our offerings include primary cells, normal and diseased iPS cell lines, iPSC-derived cell products, custom iPSC services, functional bioassay development and execution, as well as other products and services. Our unmatched expertise in genome editing, cell-based assays, immuno-oncology, and personalized medicine sets us apart.
We are dedicated to advancing scientific research and drug discovery, and we strive to maintain the highest standards of excellence in all that we do.
Products